Ashley Cordova

Companies

• NovoCure LtdChief executive officer Jan 3, 2025 to now¹
• NovoCure LtdChief financial officer Sep 4, 2020 to Aug 6, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NNovoCure Ltd NVCR422,570 shares³$6.3M at $14.88Mar 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 4, 2026Shares withheld for tax 17,638 shares at $13.30 of NovoCure Ltd³
• Mar 2, 2026Shares withheld for tax 7,228 shares at $13.67 of NovoCure Ltd⁴
• Mar 2, 2026Shares withheld for tax 2,410 shares at $13.67 of NovoCure Ltd⁴
• Feb 28, 2026Granted 23,818 shares of NovoCure Ltd⁴
• Feb 27, 2026Shares withheld for tax 11,541 shares at $13.75 of NovoCure Ltd⁴
• Sep 5, 2025Bought 81,550 shares at $12.22 of NovoCure Ltd⁵
• Jun 30, 2025Granted 833 shares at $15.13 of NovoCure Ltd⁶
• Mar 4, 2025Granted 151,181 shares at $18.19 of NovoCure Ltd⁷
• Mar 3, 2025Sold 2,053 shares at $18.54 of NovoCure Ltd⁸
• Feb 28, 2025Sold 2,341 shares at $18.28 of NovoCure Ltd⁹
• Feb 28, 2025Sold 2,341 shares at $18.28 of NovoCure Ltd¹⁰
• Feb 27, 2025Sold 1,808 shares at $20.55 of NovoCure Ltd⁹
• Feb 27, 2025Sold 1,808 shares at $20.55 of NovoCure Ltd¹⁰
• Feb 27, 2025Sold 9,345 shares at $19.92 of NovoCure Ltd⁹
• Feb 27, 2025Sold 9,345 shares at $19.92 of NovoCure Ltd¹⁰
• Dec 31, 2024Granted 373 shares at $14.75 of NovoCure Ltd¹¹
• Aug 2, 2024Sold 688 shares at $20.14 of NovoCure Ltd¹²
• Jun 28, 2024Granted 1,286 shares at $12.24 of NovoCure Ltd¹³
• Feb 27, 2024Granted 102,249 shares at $16.30 of NovoCure Ltd¹⁴
• Nov 2, 2023Exercised options 175 shares at $11.46 of NovoCure Ltd¹⁵
• Oct 31, 2023Exercised options 7,752 shares at $7.15 of NovoCure Ltd¹⁵
• Oct 31, 2023Exercised options 2,480 shares at $11.44 of NovoCure Ltd¹⁵
• Oct 31, 2023Exercised options 7,561 shares at $11.46 of NovoCure Ltd¹⁵
• Sep 1, 2023Sold 883 shares at $21.82 of NovoCure Ltd¹⁶
• Aug 2, 2023Sold 1,144 shares at $30.25 of NovoCure Ltd¹⁷